Pharma Reorganization

Bayer Chief Executive’s Big Gamble

Dekkers DPA
Bayer's CEO has a lot to prove.
  • Why it matters

    Why it matters

    If Marijn Dekker’s restructuring of Bayer succeeds, he will have created an innovative model for the life sciences industry.

  • Facts


    • Marijn Dekkers is a Dutch-American chemist and has been chief executive of Bayer since October 2010.
    • He has decided to spin off its plastics division and integrate its life sciences business.
    • The new plastics business Covestro will be floated as a seperate business this year.
  • Audio


  • Pdf
Want to keep reading?

Subscribe now or log in to read our coverage of Europe’s leading economy.